GlaxoSmithKline LLC is voluntarily recalling 328 bottles of Tivicay (dolutegravir) 50 mg Tablets because the bottles were printed with an incorrect expiration date. The label displays an expiration date of January 2027, but the medication actually expires in September 2026. No injuries or incidents have been reported in connection with this labeling error.
Using medication past its actual expiration date may lead to reduced drug effectiveness. Consumers relying on the incorrect January 2027 date might unknowingly use the product after it has lost its potency in late 2026.
You have 2 options:
The label incorrectly displays an expiration date of January 2027; the correct expiration date is September 2026.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.